Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1233223.RAWCsKhuaxkheXdoPrDcqFZiIS5qHt_uTri5kpFLfbRzI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1233223.RAWCsKhuaxkheXdoPrDcqFZiIS5qHt_uTri5kpFLfbRzI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1233223.RAWCsKhuaxkheXdoPrDcqFZiIS5qHt_uTri5kpFLfbRzI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1233223.RAWCsKhuaxkheXdoPrDcqFZiIS5qHt_uTri5kpFLfbRzI130_provenance.
- NP1233223.RAWCsKhuaxkheXdoPrDcqFZiIS5qHt_uTri5kpFLfbRzI130_assertion description "[As hyperactivation of the PI3K/AKT/mTOR pathway is frequently observed in gliomas, the combined use of ER? agonists may become a feasible therapy option to overcome chemoresistance to TMZ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233223.RAWCsKhuaxkheXdoPrDcqFZiIS5qHt_uTri5kpFLfbRzI130_provenance.
- NP1233223.RAWCsKhuaxkheXdoPrDcqFZiIS5qHt_uTri5kpFLfbRzI130_assertion evidence source_evidence_literature NP1233223.RAWCsKhuaxkheXdoPrDcqFZiIS5qHt_uTri5kpFLfbRzI130_provenance.
- NP1233223.RAWCsKhuaxkheXdoPrDcqFZiIS5qHt_uTri5kpFLfbRzI130_assertion SIO_000772 25351348 NP1233223.RAWCsKhuaxkheXdoPrDcqFZiIS5qHt_uTri5kpFLfbRzI130_provenance.
- NP1233223.RAWCsKhuaxkheXdoPrDcqFZiIS5qHt_uTri5kpFLfbRzI130_assertion wasDerivedFrom befree-2016 NP1233223.RAWCsKhuaxkheXdoPrDcqFZiIS5qHt_uTri5kpFLfbRzI130_provenance.
- NP1233223.RAWCsKhuaxkheXdoPrDcqFZiIS5qHt_uTri5kpFLfbRzI130_assertion wasGeneratedBy ECO_0000203 NP1233223.RAWCsKhuaxkheXdoPrDcqFZiIS5qHt_uTri5kpFLfbRzI130_provenance.
- befree-2016 importedOn "2016-02-19" NP1233223.RAWCsKhuaxkheXdoPrDcqFZiIS5qHt_uTri5kpFLfbRzI130_provenance.